Where is the live CopyMark page for USPTO serial 79197330?

The live record is at https://getcopymark.com/trademark/79197330. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns SCHMIDT NAGEL?

According to the public USPTO record for serial number 79197330, the listed owner(s) include: Laboratoire homéopathique D. Schmidt-Nagel SA, Laboratoire homéopathique, Laboratoire homéopathique D. Schmidt-Nagel SA, Laboratoire homéopathique D. Schmidt-Nagel SA.

What is USPTO serial number 79197330?

Serial number 79197330 is the USPTO application identifier for the mark SCHMIDT NAGEL. It is used to track examination, publication, and registration of this trademark.

Which trademark classes cover SCHMIDT NAGEL?

The public record lists International Classes: 005. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: SCHMIDT NAGEL Serial# 79197330 Reg# 5319377 | Section 8/9 renewal window is open; due Oct 31, 2027 | status 706; last event REM4 | Trademark Info & Attorney Guidance

Q: What is the current status of SCHMIDT NAGEL?

SCHMIDT NAGEL (79197330) currently shows USPTO status code 706 on the public record. This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with SCHMIDT NAGEL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Get help with this Renewal, set up monitoring, or talk with CopyMark.

Get Attorney Assistance for just $399*

Plus Government fees of $650

Trademark Monitoring (312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Matthew A. Homyk

Matthew A. Homyk Blank Rome LLPOne Logan Square, 8th FloorPhiladelphia, PA 19103United States

Goods and services

Class	Description	Status	First use
005	Homeopathic pharmaceutical preparations for use in the treatment of dry hacking cough and irritatives; [homeopathic pharmaceutical preparations for use in the treatment of urinary recovery; ] homeopathic pharmaceutical preparations for use in the treatment of occasional coughs and colds; [ homeopathic pharmaceutical preparations for use in the treatment of cystitis as a supplement to anti-infective treatments; homeopathic pharmaceutical preparations for use in the treatment of sleep disorders and anxiety; homeopathic pharmaceutical preparations for use in the treatment of regularization of the intestinal tract; homeopathic pharmaceutical preparations for use in the treatment of functional venous disorders; homeopathic pharmaceutical preparations for use in the treatment of hemorrhoids; homeopathic pharmaceutical preparations for use in facilitating digestion; homeopathic pharmaceutical preparations for use in the treatment of colic, otitis, and teething disorders; homeopathic pharmaceutical preparations for use in the treatment of eczema and psoriasis; ] homeopathic pharmaceutical preparations for use in the treatment of injuries, bruises, aches, and painful joints; [ homeopathic pharmaceutical preparations for use in the treatment of attention-deficit/hyperactivity disorder; ] homeopathic pharmaceutical preparations for use in the treatment of colds and coughs; [ homeopathic pharmaceutical preparations for use in the treatment of ear, nose, and throat disease; homeopathic pharmaceutical preparations for use in the treatment of otorhinolaryngology disease; homeopathic pharmaceutical preparations for use in the treatment of insect bites; homeopathic pharmaceutical preparations for use in the treatment of allergies; ] homeopathic supplements; medicinal creams for skin care	ACTIVE	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Nov 1, 2026	REM4	COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED	—
Sep 10, 2026	RNWL	INTERNATIONAL REGISTRATION RENEWED	—
Aug 27, 2026	ADCH	CHANGE OF NAME/ADDRESS REC'D FROM IB	—
Feb 26, 2026	INNP	PARTIAL INVALIDATION PROCESSED BY THE IB	—
Jan 9, 2026	INPS	PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB	—
Jan 9, 2026	INPC	INVALIDATION PROCESSED	—
Jul 17, 2025	INPR	PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED	—
Nov 17, 2024	NA71	NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED	—
Nov 17, 2024	71AG	REGISTERED-SEC.71 ACCEPTED	—
Nov 1, 2024	EROP	TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED	—
Jun 14, 2024	CORV	REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD	—
May 5, 2024	PUM2	OFFICE ACTION ISSUED POU2	—
Apr 23, 2024	EROP	TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED	—
Nov 6, 2023	PUM1	OFFICE ACTION ISSUED POU1	—
Nov 5, 2023	APRE	CASE ASSIGNED TO POST REGISTRATION PARALEGAL	—
Oct 19, 2023	ES71	TEAS SECTION 71 RECEIVED	—
Oct 31, 2022	REM3	COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED	—
Apr 6, 2018	FINO	FINAL DECISION TRANSACTION PROCESSED BY IB	—
Feb 7, 2018	FICS	FINAL DISPOSITION NOTICE SENT TO IB	—
Feb 7, 2018	FIMP	FINAL DISPOSITION PROCESSED	—
Jan 31, 2018	FICR	FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB	—
Oct 31, 2017	R.PR	REGISTERED-PRINCIPAL REGISTER	Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 18, 2017	GPNX	NOTIFICATION PROCESSED BY IB	—
Aug 15, 2017	NPUB	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	—
Aug 15, 2017	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 2, 2017	OPNS	NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB	—
Aug 2, 2017	OP2R	NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB	—
Jul 26, 2017	NONP	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	—
Jul 6, 2017	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Jun 13, 2017	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED	—
Jun 12, 2017	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Jun 12, 2017	TROA	TEAS RESPONSE TO OFFICE ACTION RECEIVED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 6, 2017	RFNT	REFUSAL PROCESSED BY IB	—
Dec 22, 2016	RFCS	NON-FINAL ACTION MAILED - REFUSAL SENT TO IB	—
Dec 22, 2016	RFRR	REFUSAL PROCESSED BY MPU	—
Dec 20, 2016	MAFR	APPLICATION FILING RECEIPT MAILED	—
Dec 17, 2016	RFCR	NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW	—
Dec 16, 2016	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 15, 2016	DOCK	ASSIGNED TO EXAMINER	—
Dec 15, 2016	NWOS	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED	—
Dec 9, 2016	LIMI	LIMITATION FROM ORIGINAL APPLICATION ENTERED	—
Dec 1, 2016	REPR	SN ASSIGNED FOR SECT 66A APPL FROM IB	—

SCHMIDT NAGEL